Intel vs Johnson & Johnson: Founders, CEOs and History
Intel was founded in 1968 by Robert Noyce, Gordon Moore and is led by Lip-Bu Tan. Johnson & Johnson was founded in 1886 by Robert Wood Johnson, James Wood Johnson, Edward Mead Johnson and is led by Joaquin Duato.
Company facts
Intel
- Founded
- 1968
- Headquarters
- Santa Clara, California
- Current CEO
- Lip-Bu Tan
- Employees
- 85,100
Johnson & Johnson
- Founded
- 1886
- Headquarters
- New Brunswick, New Jersey
- Current CEO
- Joaquin Duato
- Employees
- 140,800
Founders
Intel
Robert Noyce
Intel possesses the most well-known founding story in the entire history of Silicon Valley, famously founded by the effective, rebellious engineers who essentially invented the fundamental architecture of the modern digital world.
Gordon Moore
Gordon Moore co-founded Intel and served as a key technical leader, CEO, and chairman during the company's formative decades. His most important contribution was turning transistor scaling into a corporate operating philosophy.
Johnson & Johnson
Robert Wood Johnson
Robert Wood Johnson (1845-1910) co-founded Johnson & Johnson in 1886 and served as its first president.
James Wood Johnson
James Wood Johnson (1856-1932) co-founded J&J with his brothers in 1886. An engineer by trade, he designed the early manufacturing machinery that allowed the company to mass-produce sterile surgical dressings.
Edward Mead Johnson
Edward Mead Johnson (1852-1934) co-founded J&J in 1886, bringing crucial sales and marketing expertise to the early business.
CEOs and their tenures
Intel
- Andy Grove1987–1998
CEO
Grove turned Intel into the dominant PC processor supplier; revenue grew from about $1.9B in 1987 to over $26B in 1998. His book 'Only the Paranoid Survive' became a management classic.
Source - Pat Gelsinger2021–2024
CEO
Gelsinger rebuilt Intel's process roadmap toward 18A, but capital spending outpaced revenue. After a $18.8B net loss in 2024 and a dividend suspension, the board pushed him out in December 2024.
Source - Lip-Bu Tan2025–present
Chief Executive Officer
Tan reframed Intel around customer commitments and cost discipline rather than building capacity ahead of demand. By Q2 2026 Intel had beaten guidance for several straight quarters and posted its fastest revenue growth in more than 15 years.
Source
Johnson & Johnson
- Ralph Larsen1989–2002
Former Chairman and Chief Executive Officer
Larsen's acquisitions, including Neutrogena, Cordis, DePuy, and Centocor, broadened J&J into medical devices and biologics, laying groundwork for today's MedTech segment and immunology franchise.
Source - William Weldon2002–2012
Former Chairman and Chief Executive Officer
Weldon's later years were overshadowed by a wave of consumer product recalls, including Tylenol and Motrin, tied to manufacturing-quality problems.
Source - Alex Gorsky2012–2022
Former Chairman and Chief Executive Officer
Gorsky's tenure set up the 2023 Kenvue separation completed under his successor and saw J&J's single-dose COVID-19 vaccine authorized in 2021. He also oversaw the $30 billion Actelion acquisition in 2017 and the early years of talc litigation.
Source - Joaquin Duato2022–present
Chairman and Chief Executive Officer
Under Duato, J&J's sales reached $94.193 billion in FY2025 with $26.804 billion in net earnings, and the company guides to its first $100 billion year in 2026. He also launched the DePuy Synthes separation and the 2026 talc settlement proposal.
Source
Timeline: Intel and Johnson & Johnson side by side
1886Johnson & Johnson
Johnson & Johnson Founded
Robert Wood Johnson, James Wood Johnson, and Edward Mead Johnson found the company in New Brunswick, New Jersey, with 14 employees, to mass-produce sterile surgical dressings after Robert was inspired by antiseptic pioneer Joseph Lister's 1885 warnings about i…
1920Johnson & Johnson
Band-Aid Brand Adhesive Bandages Introduced
J&J introduces the first mass-produced adhesive bandage, sold under the Band-Aid brand starting in 1921; it becomes one of the most recognized consumer-health brands in the world before J&J later spins its consumer division out as Kenvue in 2023.
1943Johnson & Johnson
Robert Wood Johnson II Writes 'Our Credo'
Chairman Robert Wood Johnson II authors 'Our Credo,' a one-page statement ranking the company's responsibilities to customers, employees, communities, and shareholders in that order; it remains J&J's official governing philosophy and was later cited as the bas…
1944Johnson & Johnson
J&J Goes Public
Johnson & Johnson lists publicly, becoming an independent, market-traded company as it expands into a diversified healthcare business under Chairman Robert Wood Johnson II.
1968Intel
Intel Founded
Robert Noyce and Gordon Moore founded Intel.
1971Intel
4004 Microprocessor
Intel introduced the 4004, one of the first commercial microprocessors.
1982Johnson & Johnson
Tylenol Cyanide Poisonings and Nationwide Recall
After seven people in the Chicago area die from cyanide-laced Extra-Strength Tylenol capsules, J&J issues a nationwide recall of 31 million bottles within a week -- far beyond what investigators said was necessary -- citing Our Credo's customer-safety priority…
1985Intel
386 Processor
Intel strengthened the x86 franchise that later dominated PCs.
1993Intel
Pentium Processor Launched
Intel introduced the Pentium processor in 1993.
2006Intel
Core Architecture
Intel revived product leadership with the Core architecture.
2012Johnson & Johnson
Alex Gorsky Becomes CEO
Gorsky succeeds William Weldon as CEO amid a period of manufacturing-quality recalls, and spends the next decade restoring J&J's operational reputation while expanding the pharmaceutical and MedTech businesses and developing a single-dose COVID-19 vaccine duri…
2021Intel
IDM 2.0 Announced
Intel announced a strategy to expand manufacturing and foundry capabilities.
2021Intel
Pat Gelsinger Becomes CEO
Pat Gelsinger became Intel chief executive in February 2021.
2022Johnson & Johnson
Joaquin Duato Becomes CEO
Duato becomes CEO in January 2022, later adding the chairman title, and begins preparing the separation of J&J's consumer-health business from its medicine and device operations.
2023Johnson & Johnson
Kenvue Separation
J&J completes the spinoff of its consumer-health business (Band-Aid, Tylenol, Listerine, Neutrogena) as the standalone public company Kenvue, narrowing J&J around its higher-margin Innovative Medicine and MedTech segments.
2025Intel
Lip-Bu Tan Becomes CEO
Lip-Bu Tan became CEO and reset the turnaround agenda around execution, cost, and focus.
2025Intel
$52.853B Revenue
Intel reported $52.853B in revenue and a $267M net loss attributable to Intel.
2025Intel
U.S. Government Takes 9.9% Stake
The U.S. government bought 433.3 million Intel shares at $20.47 for $8.9 billion, becoming the largest shareholder.
2025Intel
Nvidia Invests $5 Billion
Nvidia agreed to invest $5 billion in Intel and co-develop x86 PC and data-center products.
2025Intel
Altera Majority Sold
Intel closed the sale of 51% of Altera to Silver Lake on September 12, 2025.
2025Johnson & Johnson
FY2025 Sales of $94.193B
Johnson & Johnson reports $94.193 billion in sales and $26.804 billion in net earnings, split roughly 64% Innovative Medicine and 36% MedTech, both segments growing about 6% year over year.
2025Johnson & Johnson
Orthopaedics Separation Announced
In October 2025 J&J announced plans to separate its orthopaedics business as a standalone company operating as DePuy Synthes, targeting completion in 2027.
2026Intel
Q2 Revenue Up 25%
Intel reported $16.1 billion in Q2 2026 revenue, its fastest growth in more than 15 years.
2026Johnson & Johnson
Proposed Talc Resolution and Raised Guidance
J&J raised 2026 sales guidance to about $101.1 billion after Q2 sales of $25.31 billion, and on July 27, 2026 proposed an estimated $5.5 billion resolution of remaining ovarian talc claims.
Acquisitions
Intel
- Moovit2020$900M
- Habana Labs2019$2B
- Mobileye2017$15.3B
- Altera2015$16.7B
- McAfee2011$7.7B
Johnson & Johnson
- Intra-Cellular Therapies2025$14.6B
- Shockwave Medical2024$13.1B
- Kenvue separation2023Undisclosed
- Abiomed2022$16.6B
- Actelion2017$30B
Questions about Intel vs Johnson & Johnson
Who is the CEO of Intel Corporation and Johnson & Johnson?
Intel Corporation is led by Lip-Bu Tan and Johnson & Johnson is led by Joaquin Duato. Both serve as the top executive responsible for the company's strategy, operations, and financial performance.
When was Intel Corporation founded vs Johnson & Johnson?
Johnson & Johnson was founded in 1886 — 82 years before Intel Corporation, which was founded in 1968. Johnson & Johnson's longer operating history gives it a deeper track record but also potentially more institutional inertia compared to the younger Intel Corporation.
How many employees does Intel Corporation have compared to Johnson & Johnson?
Intel Corporation employs approximately 85,100 people, while Johnson & Johnson employs approximately 140,800. Johnson & Johnson has the larger workforce at 140,800 employees, compared to Intel Corporation's 85,100. A higher headcount does not necessarily imply greater efficiency — it often reflects differences in business model (e.g., manufacturing vs. software).
Where are Intel Corporation and Johnson & Johnson headquartered?
Both Intel Corporation and Johnson & Johnson are headquartered in United States, meaning they operate under the same primary regulatory and tax environment.
Who founded Intel Corporation and Johnson & Johnson?
Intel Corporation was founded by Robert Noyce, Gordon Moore. Johnson & Johnson was founded by Robert Wood Johnson, James Wood Johnson, Edward Mead Johnson.
Which company has a longer operating history — Intel Corporation or Johnson & Johnson?
Johnson & Johnson has been operating for approximately 140 years, making it the more established of the two companies. Intel Corporation has been in operation for around 58 years. A longer operating history often signals greater institutional resilience and brand recognition, though it can also mean slower adaptation to new market conditions.
Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the Intel vs Johnson & Johnson overview